Keith Hyland
Corporate Officer/Principal at LABORATORY CORPORATION OF AMERICA HOLDINGS
Profile
Keith Hyland is the founder of Medical Neurogenetics LLC.
He is currently working as the Department of Neurochemistry at Laboratory Corp.
of America Holdings.
Previously, he worked as the Laboratory Director at Institute of Metabolic Disease and as the Director-Neurochemistry at Horizon Molecular Medicine.
Dr. Hyland completed his undergraduate and doctorate degrees from Brunel University in 1976 and 1980 respectively.
Keith Hyland active positions
| Companies | Position | Start |
|---|---|---|
| LABORATORY CORPORATION OF AMERICA HOLDINGS | Corporate Officer/Principal | - |
Former positions of Keith Hyland
| Companies | Position | End |
|---|---|---|
| Horizon Molecular Medicine | Corporate Officer/Principal | - |
Medical Neurogenetics LLC
 Medical Neurogenetics LLC Medical/Nursing ServicesHealth Services Medical Neurogenetics LLC specializes in neurogenetic and complex biochemical testing. It offers a complete neurogenetic testing menu and provides NGS tests for various genetic and inherited neurological conditions affecting children and adults, including epilepsy, muscular dystrophy, Parkinson’s, Alzheimer’s, and cellular energetics defects. The company was founded in 2001 and is headquartered in Atlanta, GA. | Founder | - |
| Institute of Metabolic Disease | Corporate Officer/Principal | - |
Training of Keith Hyland
| Brunel University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| LABORATORY CORPORATION OF AMERICA HOLDINGS | Health Services |
| Private companies | 3 |
|---|---|
Medical Neurogenetics LLC
Medical Neurogenetics LLC Medical/Nursing ServicesHealth Services Medical Neurogenetics LLC specializes in neurogenetic and complex biochemical testing. It offers a complete neurogenetic testing menu and provides NGS tests for various genetic and inherited neurological conditions affecting children and adults, including epilepsy, muscular dystrophy, Parkinson’s, Alzheimer’s, and cellular energetics defects. The company was founded in 2001 and is headquartered in Atlanta, GA. | Health Services |
| Institute of Metabolic Disease | |
| Horizon Molecular Medicine |
- Stock Market
- Insiders
- Keith Hyland
